Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Shimada

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 21, 2019
In vivo binding of a tau imaging probe, [<sup>11</sup> C]PBB3, in patients with progressive supranuclear palsyHironobu Endo, Hitoshi Shimada, Naruhiko Sahara, et al.
Movement Disorders Clinical Practice|April 12, 2024
Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ MutationHiroyuki Morino, Takashi Kurashige, Yukiko Matsuda, et al.
Journal of the Neurological Sciences|December 6, 2022
Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsyKiwamu Matsuoka, Yuhei Takado, Kenji Tagai, et al.
Annals of Neurology|September 13, 2023
Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's DiseaseKosei Hirata, Kiwamu Matsuoka, Kenji Tagai, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 10, 2023
CenTauR: Toward a universal scale and masks for standardizing tau imaging studiesVictor L Villemagne, Antoine Leuzy, Sandra Sanabria Bohorquez, et al.
The International Journal of Neuropsychopharmacology|December 19, 2013
Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂Harumasa Takano, Ryosuke Arakawa, Tsuyoshi Nogami, et al.
The International Journal of Neuropsychopharmacology|October 17, 2012
Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2)Tsuyoshi Nogami, Harumasa Takano, Ryosuke Arakawa, et al.
Neuroimage|November 25, 2022
An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with <sup>18</sup>F-PM-PBB3 (<sup>18</sup>F-APN-1607)Kenji Tagai, Yoko Ikoma, Hironobu Endo, et al.
Neuropsychiatric Disease and Treatment|October 2, 2019
Differentiation Between Dementia With Lewy Bodies And Alzheimer's Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter StudyHiroshi Matsuda, Kota Yokoyama, Noriko Sato, et al.
Parkinsonism & Related Disorders|May 9, 2022
PET-based classification of corticobasal syndromeYoshikazu Nakano, Hitoshi Shimada, Hitoshi Shinotoh, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Movement Disorders : Official Journal of the Movement Disorder Society|March 21, 2019
In vivo binding of a tau imaging probe, [<sup>11</sup> C]PBB3, in patients with progressive supranuclear palsyHironobu Endo, Hitoshi Shimada, Naruhiko Sahara, et al.
Movement Disorders Clinical Practice|April 12, 2024
Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ MutationHiroyuki Morino, Takashi Kurashige, Yukiko Matsuda, et al.
Journal of the Neurological Sciences|December 6, 2022
Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsyKiwamu Matsuoka, Yuhei Takado, Kenji Tagai, et al.
Annals of Neurology|September 13, 2023
Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's DiseaseKosei Hirata, Kiwamu Matsuoka, Kenji Tagai, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 10, 2023
CenTauR: Toward a universal scale and masks for standardizing tau imaging studiesVictor L Villemagne, Antoine Leuzy, Sandra Sanabria Bohorquez, et al.
The International Journal of Neuropsychopharmacology|December 19, 2013
Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂Harumasa Takano, Ryosuke Arakawa, Tsuyoshi Nogami, et al.
The International Journal of Neuropsychopharmacology|October 17, 2012
Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2)Tsuyoshi Nogami, Harumasa Takano, Ryosuke Arakawa, et al.
Neuroimage|November 25, 2022
An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with <sup>18</sup>F-PM-PBB3 (<sup>18</sup>F-APN-1607)Kenji Tagai, Yoko Ikoma, Hironobu Endo, et al.
Neuropsychiatric Disease and Treatment|October 2, 2019
Differentiation Between Dementia With Lewy Bodies And Alzheimer's Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter StudyHiroshi Matsuda, Kota Yokoyama, Noriko Sato, et al.
Parkinsonism & Related Disorders|May 9, 2022
PET-based classification of corticobasal syndromeYoshikazu Nakano, Hitoshi Shimada, Hitoshi Shinotoh, et al.
Pageof 10